Italian  	Italian  	 JJ	O
cancer  	cancer  	 NN	B-NP
figures 	figures 	 NNS	I-NP
,  	,  	 ,	O
report  	report  	 NN	O
2013 	2013 	 CD	O
:  	:  	 :	O
Multiple  	Multiple  	 NNP	B-NP
tumours  	tumours  	 VBD	I-NP
This  	This  	 DT	O
collaborative  	collaborative  	 JJ	B-NP
study 	study 	 NN	I-NP
,  	,  	 ,	O
based  	based  	 VBN	O
on  	on  	 IN	O
data  	data  	 NNS	O
collected  	collected  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
network  	network  	 NN	O
of  	of  	 IN	O
Italian  	Italian  	 JJ	O
association  	association  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	B-NP
registries  	registries  	 NNS	I-NP
( 	( 	 -LRB-	O
AIRTUM 	AIRTUM 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
provides  	provides  	 VBZ	O
updated  	updated  	 VBN	B-NP
estimates  	estimates  	 NNS	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
incidence  	incidence  	 JJ	B-NP
risk  	risk  	 NN	I-NP
of  	of  	 IN	O
multiple  	multiple  	 JJ	O
primary  	primary  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
( 	( 	 -LRB-	O
MP 	MP 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
is  	is  	 VBZ	O
to  	to  	 TO	O
highlight  	highlight  	 VB	O
and  	and  	 CC	O
quantify  	quantify  	 VB	O
the  	the  	 DT	O
bidirectional  	bidirectional  	 JJ	B-NP
associations  	associations  	 NNS	I-NP
between  	between  	 IN	O
different  	different  	 JJ	O
oncological  	oncological  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
quantification  	quantification  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
excess  	excess  	 NN	O
or  	or  	 CC	O
decreased  	decreased  	 JJ	O
risk  	risk  	 NN	O
of  	of  	 IN	O
further  	further  	 JJ	O
cancers  	cancers  	 NNS	O
in  	in  	 IN	O
cancer  	cancer  	 NN	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
comparison  	comparison  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
general  	general  	 JJ	O
population 	population 	 NN	O
,  	,  	 ,	O
may  	may  	 MD	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
understand  	understand  	 VB	O
the  	the  	 DT	O
aetiology  	aetiology  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	O
and  	and  	 CC	O
to  	to  	 TO	O
address  	address  	 VB	O
clinical  	clinical  	 JJ	B-NP
follow-up 	follow-up 	 NN	I-NP
.  	.  	 .	O
Data  	Data  	 NNS	O
herein  	herein  	 VBP	O
presented  	presented  	 VBN	O
were  	were  	 VBD	O
provided  	provided  	 VBN	O
by  	by  	 IN	O
AIRTUM  	AIRTUM  	 NNP	B-NP
population-based  	population-based  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
registries 	registries 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
cover  	cover  	 VBP	O
nowadays  	nowadays  	 RB	O
48 	48 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Italian  	Italian  	 JJ	O
population 	population 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
monograph  	monograph  	 NN	O
utilizes  	utilizes  	 VBD	O
the  	the  	 DT	O
AIRTUM  	AIRTUM  	 NNP	B-NP
database  	database  	 NN	I-NP
( 	( 	 -LRB-	O
December  	December  	 NNP	O
2012 	2012 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
considering  	considering  	 VBG	O
all  	all  	 DT	O
malignant  	malignant  	 JJ	O
cancer  	cancer  	 NN	B-NP
cases  	cases  	 NNS	I-NP
diagnosed  	diagnosed  	 VBN	O
between  	between  	 IN	O
1976  	1976  	 CD	O
and  	and  	 CC	O
2010 	2010 	 CD	O
.  	.  	 .	O
All  	All  	 DT	O
cases  	cases  	 NNS	O
are  	are  	 VBP	O
coded  	coded  	 VBN	O
according  	according  	 VBG	O
to  	to  	 TO	O
ICD-O-3 	ICD-O-3 	 CD	B-NP
.  	.  	 .	O
Non-melanoma  	Non-melanoma  	 JJ	B-NP
skin  	skin  	 NN	I-NP
cancer  	cancer  	 NN	I-NP
cases 	cases 	 NNS	I-NP
,  	,  	 ,	O
cases  	cases  	 NNS	O
based  	based  	 VBN	O
on  	on  	 IN	O
death  	death  	 NN	B-NP
certificate  	certificate  	 NN	I-NP
only 	only 	 RB	O
,  	,  	 ,	O
cases  	cases  	 NNS	O
based  	based  	 VBN	O
on  	on  	 IN	O
autopsy  	autopsy  	 VBG	O
only 	only 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
cases  	cases  	 NNS	O
with  	with  	 IN	O
follow-up  	follow-up  	 JJ	B-NP
time  	time  	 NN	I-NP
equal  	equal  	 JJ	O
to  	to  	 TO	O
zero  	zero  	 CD	O
were  	were  	 VBD	O
excluded 	excluded 	 VBN	O
.  	.  	 .	O
To  	To  	 TO	O
define  	define  	 VB	O
multiple  	multiple  	 JJ	O
primaries 	primaries 	 NN	O
,  	,  	 ,	O
IARC-IACR  	IARC-IACR  	 JJ	B-NP
rules  	rules  	 NNS	I-NP
were  	were  	 VBD	O
adopted  	adopted  	 VBN	O
( 	( 	 -LRB-	O
http 	http 	 NN	B-NP
: 	: 	 :	O
-www.iacr.com.fr 	-www.iacr.com.fr 	 CD	O
/ 	/ 	 CD	O
MPrules_july2004.pdf 	MPrules_july2004.pdf 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Data  	Data  	 NNP	O
were  	were  	 VBD	O
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
standard  	standard  	 JJ	O
quality  	quality  	 NN	B-NP
control  	control  	 NN	I-NP
procedures  	procedures  	 NNS	I-NP
( 	( 	 -LRB-	O
described  	described  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
AIRTUM  	AIRTUM  	 NNP	B-NP
data  	data  	 NN	I-NP
management  	management  	 NN	I-NP
protocol 	protocol 	 NN	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
specific  	specific  	 JJ	O
quality  	quality  	 NN	B-NP
control  	control  	 NN	I-NP
checks  	checks  	 NNS	I-NP
defined  	defined  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study 	study 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
patients  	patients  	 NNS	I-NP
was  	was  	 VBD	O
followed  	followed  	 VBN	O
over  	over  	 IN	O
time  	time  	 NN	O
from  	from  	 IN	O
first  	first  	 JJ	O
cancer  	cancer  	 NN	B-NP
diagnosis  	diagnosis  	 NN	I-NP
until  	until  	 IN	O
the  	the  	 DT	O
date  	date  	 NN	O
of  	of  	 IN	O
second  	second  	 JJ	O
cancer  	cancer  	 NN	B-NP
diagnosis 	diagnosis 	 NN	I-NP
,  	,  	 ,	O
death 	death 	 NN	O
,  	,  	 ,	O
or  	or  	 CC	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
follow-up 	follow-up 	 NNP	O
,  	,  	 ,	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
whether  	whether  	 IN	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
observed  	observed  	 JJ	O
second  	second  	 JJ	O
cancer  	cancer  	 NN	B-NP
cases  	cases  	 NNS	I-NP
was  	was  	 VBD	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
expected 	expected 	 VBN	O
.  	.  	 .	O
Person  	Person  	 NN	O
years  	years  	 NNS	O
at  	at  	 IN	O
risk  	risk  	 NN	O
( 	( 	 -LRB-	O
PY 	PY 	 NNP	B-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
computed  	computed  	 VBN	O
by  	by  	 IN	O
first  	first  	 JJ	O
cancer  	cancer  	 NN	B-NP
site 	site 	 NN	I-NP
,  	,  	 ,	O
geographic  	geographic  	 JJ	B-NP
area  	area  	 NN	I-NP
( 	( 	 -LRB-	O
North 	North 	 NNP	O
,  	,  	 ,	O
Centre 	Centre 	 NNP	O
,  	,  	 ,	O
South  	South  	 NNP	O
and  	and  	 CC	O
Islands 	Islands 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
attained  	attained  	 JJ	O
age 	age 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
attained  	attained  	 JJ	O
calendar-year  	calendar-year  	 JJ	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
All  	All  	 DT	O
second  	second  	 JJ	O
cancers  	cancers  	 NNS	O
diagnosed  	diagnosed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
cohort 	cohort 	 NN	O
's  	's  	 POS	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
observed  	observed  	 JJ	O
numbers  	numbers  	 NNS	O
of  	of  	 IN	O
cases 	cases 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
expected  	expected  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	B-NP
cases  	cases  	 NNS	I-NP
was  	was  	 VBD	O
computed  	computed  	 VBN	O
multiplying  	multiplying  	 VBG	O
the  	the  	 DT	O
accumulated  	accumulated  	 JJ	O
PY  	PY  	 NN	B-NP
by  	by  	 IN	O
the  	the  	 DT	O
expected  	expected  	 JJ	O
rates 	rates 	 NNS	O
,  	,  	 ,	O
calculated  	calculated  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
AIRTUM  	AIRTUM  	 NNP	B-NP
database  	database  	 NN	I-NP
stratified  	stratified  	 NN	I-NP
by  	by  	 IN	O
cancer  	cancer  	 NN	B-NP
site 	site 	 NN	I-NP
,  	,  	 ,	O
geographic  	geographic  	 JJ	B-NP
area 	area 	 NN	I-NP
,  	,  	 ,	O
age 	age 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
calendar-year  	calendar-year  	 JJ	B-NP
group 	group 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
Standardized  	Standardized  	 NNP	B-NP
Incidence  	Incidence  	 NNP	I-NP
Ratio  	Ratio  	 NNP	I-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
calculated  	calculated  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
ratio  	ratio  	 NN	O
of  	of  	 IN	O
observed  	observed  	 JJ	O
to  	to  	 TO	O
expected  	expected  	 JJ	O
cancer  	cancer  	 NN	B-NP
cases 	cases 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
Excess  	Excess  	 NNP	B-NP
Absolute  	Absolute  	 NNP	I-NP
Risk  	Risk  	 NNP	I-NP
( 	( 	 -LRB-	O
EAR 	EAR 	 NNP	B-NP
)  	)  	 -RRB-	O
beyond  	beyond  	 IN	O
the  	the  	 DT	O
expected  	expected  	 JJ	O
amount  	amount  	 NN	O
were  	were  	 VBD	O
calculated  	calculated  	 VBN	O
subtracting  	subtracting  	 VBG	O
the  	the  	 DT	O
expected  	expected  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
subsequent  	subsequent  	 JJ	O
cancers  	cancers  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
observed  	observed  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	B-NP
cases 	cases 	 NNS	I-NP
;  	;  	 :	O
the  	the  	 DT	O
difference  	difference  	 NN	O
was  	was  	 VBD	O
then  	then  	 RB	O
divided  	divided  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
PY  	PY  	 NNP	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	B-NP
cases  	cases  	 NNS	I-NP
in  	in  	 IN	O
excess  	excess  	 JJ	O
( 	( 	 -LRB-	O
or  	or  	 CC	O
deficit 	deficit 	 NN	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
expressed  	expressed  	 VBN	O
per  	per  	 IN	O
1,000  	1,000  	 CD	O
PY 	PY 	 NNS	B-NP
.  	.  	 .	O
Confidence  	Confidence  	 NN	B-NP
intervals  	intervals  	 NNS	I-NP
were  	were  	 VBD	O
stated  	stated  	 VBN	O
at  	at  	 IN	O
95 	95 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
two  	two  	 CD	O
months  	months  	 NNS	O
( 	( 	 -LRB-	O
60  	60  	 CD	O
days 	days 	 NNS	O
)  	)  	 -RRB-	O
after  	after  	 IN	O
first  	first  	 JJ	O
cancer  	cancer  	 NN	B-NP
diagnosis  	diagnosis  	 NN	I-NP
were  	were  	 VBD	O
defined  	defined  	 VBN	O
as  	as  	 IN	O
synchronicity  	synchronicity  	 JJ	B-NP
period 	period 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
main  	main  	 JJ	O
analysis  	analysis  	 NN	O
observed  	observed  	 VBD	O
and  	and  	 CC	O
expected  	expected  	 JJ	O
cases  	cases  	 NNS	O
during  	during  	 IN	O
this  	this  	 DT	O
period  	period  	 NN	O
were  	were  	 VBD	O
excluded 	excluded 	 VBN	O
.  	.  	 .	O
It  	It  	 PRP	O
was  	was  	 VBD	O
estimated  	estimated  	 VBN	O
the  	the  	 DT	O
excess  	excess  	 JJ	O
risk  	risk  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
period  	period  	 NN	O
after  	after  	 IN	O
first  	first  	 JJ	O
diagnosis  	diagnosis  	 NN	O
( 	( 	 -LRB-	O
≥  	≥  	 CD	O
0  	0  	 CD	O
months 	months 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
excluding  	excluding  	 VBG	O
the  	the  	 DT	O
synchronicity  	synchronicity  	 JJ	B-NP
period  	period  	 NN	I-NP
( 	( 	 -LRB-	O
≥  	≥  	 CD	O
2  	2  	 CD	O
months 	months 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
during  	during  	 IN	O
the  	the  	 DT	O
following  	following  	 JJ	O
periods 	periods 	 NNS	O
:  	:  	 :	O
2-11 	2-11 	 CD	O
,  	,  	 ,	O
12-59 	12-59 	 NNP	O
,  	,  	 ,	O
60-119  	60-119  	 NNP	O
and  	and  	 CC	O
120  	120  	 CD	O
months  	months  	 NNS	O
after  	after  	 IN	O
diagnosis 	diagnosis 	 NN	O
.  	.  	 .	O
First-cancer-site-and-gender-specific  	First-cancer-site-and-gender-specific  	 JJ	B-NP
sheets  	sheets  	 NNS	I-NP
are  	are  	 VBP	O
presented 	presented 	 VBN	O
,  	,  	 ,	O
reporting  	reporting  	 VBG	O
both  	both  	 DT	O
SIRs  	SIRs  	 JJ	O
and  	and  	 CC	O
EARs 	EARs 	 JJ	O
.  	.  	 .	O
For  	For  	 IN	O
5,979,338  	5,979,338  	 CD	O
person-years  	person-years  	 JJ	B-NP
a  	a  	 DT	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	O
1,635,060  	1,635,060  	 CD	O
cancer  	cancer  	 NN	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
880,361  	880,361  	 CD	O
males  	males  	 NNS	O
and  	and  	 CC	O
754,699  	754,699  	 CD	O
females 	females 	 NNS	O
)  	)  	 -RRB-	O
diagnosed  	diagnosed  	 VBD	O
between  	between  	 IN	O
1976  	1976  	 CD	O
and  	and  	 CC	O
2010  	2010  	 CD	O
was  	was  	 VBD	O
followed 	followed 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
mean  	mean  	 JJ	O
follow-up  	follow-up  	 JJ	B-NP
length  	length  	 NN	I-NP
was  	was  	 VBD	O
14  	14  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
Overall 	Overall 	 RB	O
,  	,  	 ,	O
85,399  	85,399  	 CD	O
metachronous  	metachronous  	 NNS	B-NP
( 	( 	 -LRB-	O
latency  	latency  	 CD	B-NP
≥2  	≥2  	 CD	O
months 	months 	 NNS	O
)  	)  	 -RRB-	O
cancers  	cancers  	 NNS	O
were  	were  	 VBD	O
observed 	observed 	 VBN	O
,  	,  	 ,	O
while  	while  	 IN	O
77,813  	77,813  	 NNP	O
were  	were  	 VBD	O
expected  	expected  	 VBN	O
during  	during  	 IN	O
the  	the  	 DT	O
study  	study  	 NN	B-NP
period 	period 	 NN	I-NP
:  	:  	 :	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.10  	1.10  	 CD	O
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
1.09-1.10 	1.09-1.10 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
EAR 	EAR 	 NNP	O
:  	:  	 :	O
1.32  	1.32  	 CD	O
x  	x  	 SYM	O
1,000  	1,000  	 CD	O
person-years  	person-years  	 NNS	B-NP
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
1.19  	1.19  	 CD	O
-  	-  	 :	O
1.46 	1.46 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
SIR  	SIR  	 NNP	O
was  	was  	 VBD	O
1.08  	1.08  	 CD	O
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
1.08-1.09 	1.08-1.09 	 NNP	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
men  	men  	 NNS	O
( 	( 	 -LRB-	O
54,518  	54,518  	 NNP	O
observed  	observed  	 VBD	O
and  	and  	 CC	O
50,260  	50,260  	 RB	O
expected 	expected 	 VBN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
1.12  	1.12  	 CD	O
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
1.11-1.13 	1.11-1.13 	 NNP	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
women  	women  	 NNS	O
( 	( 	 -LRB-	O
30,881 	30,881 	 CD	O
/ 	/ 	 CD	O
27,553 	27,553 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
EAR  	EAR  	 NNP	O
1.61  	1.61  	 NNP	O
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
1.37-1.84 	1.37-1.84 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
1.08  	1.08  	 CD	O
x  	x  	 SYM	O
1,000  	1,000  	 CD	O
person-years  	person-years  	 NNS	B-NP
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
0.93-1.24 	0.93-1.24 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
respectively.Moreover 	respectively.Moreover 	 NNP	O
,  	,  	 ,	O
during  	during  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
two  	two  	 CD	O
months  	months  	 NNS	O
after  	after  	 IN	O
first  	first  	 JJ	O
cancer  	cancer  	 NN	B-NP
diagnosis  	diagnosis  	 NN	I-NP
( 	( 	 -LRB-	O
synchronous  	synchronous  	 JJ	B-NP
period 	period 	 NN	I-NP
)  	)  	 -RRB-	O
14,807  	14,807  	 CD	O
cancers  	cancers  	 NNS	O
were  	were  	 VBD	O
observed  	observed  	 VBN	O
while  	while  	 IN	O
3,536  	3,536  	 NNP	O
were  	were  	 VBD	O
expected  	expected  	 VBN	O
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
4.16 	4.16 	 CD	O
;  	;  	 :	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
4.09-4.22 	4.09-4.22 	 NNP	O
) 	) 	 -RRB-	O
;  	;  	 :	O
the  	the  	 DT	O
SIR  	SIR  	 NNP	O
was  	was  	 VBD	O
4.08  	4.08  	 CD	O
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
4.00-4.16 	4.00-4.16 	 NNP	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
men  	men  	 NNS	O
and  	and  	 CC	O
4.32  	4.32  	 CD	O
( 	( 	 -LRB-	O
95 	95 	 CD	O
% 	% 	 NN	O
CI  	CI  	 NNP	O
4.20-4.45 	4.20-4.45 	 NNP	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
women.The  	women.The  	 CD	O
mean  	mean  	 JJ	O
age  	age  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
at  	at  	 IN	O
first  	first  	 JJ	O
cancer  	cancer  	 NN	B-NP
diagnosis  	diagnosis  	 NN	I-NP
was  	was  	 VBD	O
67.0  	67.0  	 CD	O
years  	years  	 NNS	O
among  	among  	 IN	O
males  	males  	 NNS	O
and  	and  	 CC	O
65.8  	65.8  	 CD	O
among  	among  	 IN	O
females.The  	females.The  	 CD	O
risk  	risk  	 NN	O
of  	of  	 IN	O
MP  	MP  	 NNP	B-NP
was  	was  	 VBD	O
related  	related  	 VBN	O
to  	to  	 TO	O
age  	age  	 NN	O
being  	being  	 VBG	O
higher  	higher  	 JJR	O
for  	for  	 IN	O
younger  	younger  	 JJR	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
lower  	lower  	 JJR	O
for  	for  	 IN	O
older  	older  	 JJR	O
ones 	ones 	 NNS	B-NP
.  	.  	 .	O
In  	In  	 IN	O
relation  	relation  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
time  	time  	 NN	O
of  	of  	 IN	O
first  	first  	 JJ	O
cancer  	cancer  	 NN	B-NP
diagnosis 	diagnosis 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
SIR  	SIR  	 NNP	O
was  	was  	 VBD	O
very  	very  	 RB	O
high  	high  	 JJ	O
at  	at  	 IN	O
the  	the  	 DT	O
beginning  	beginning  	 NN	O
and  	and  	 CC	O
then  	then  	 RB	O
decreased 	decreased 	 VBN	O
,  	,  	 ,	O
although  	although  	 IN	O
remaining  	remaining  	 VBG	O
constantly  	constantly  	 RB	O
over  	over  	 IN	O
1 	1 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
then  	then  	 RB	O
rose  	rose  	 VBD	O
over  	over  	 IN	O
time 	time 	 NN	O
.  	.  	 .	O
No  	No  	 DT	O
strong  	strong  	 JJ	O
differences  	differences  	 NNS	O
were  	were  	 VBD	O
evident  	evident  	 JJ	O
across  	across  	 IN	O
the  	the  	 DT	O
different  	different  	 JJ	O
incidence  	incidence  	 NN	B-NP
periods 	periods 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
all  	all  	 RB	O
showed  	showed  	 VBD	O
an  	an  	 DT	O
increased  	increased  	 JJ	O
MP  	MP  	 NNP	B-NP
risk.Women  	risk.Women  	 NNP	I-NP
had  	had  	 VBD	O
higher  	higher  	 JJR	O
SIRs  	SIRs  	 NN	O
than  	than  	 IN	O
expected  	expected  	 VBN	O
for  	for  	 IN	O
18  	18  	 CD	O
cancer  	cancer  	 NN	B-NP
sites 	sites 	 NNS	I-NP
,  	,  	 ,	O
men  	men  	 NNS	O
for  	for  	 IN	O
12 	12 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
statistically  	statistically  	 NN	O
significantly  	significantly  	 RB	O
SIRs  	SIRs  	 JJ	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
1  	1  	 CD	O
were  	were  	 VBD	O
2  	2  	 CD	O
and  	and  	 CC	O
8 	8 	 CD	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Increased  	Increased  	 VBN	O
overall  	overall  	 JJ	O
MP  	MP  	 NNP	B-NP
risk  	risk  	 NN	I-NP
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
patients  	patients  	 NNS	O
of  	of  	 IN	O
both  	both  	 DT	O
sexes  	sexes  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
first  	first  	 JJ	O
primary  	primary  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
oral  	oral  	 JJ	B-NP
cavity  	cavity  	 NNS	I-NP
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.93 	1.93 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.48 	1.48 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
pharynx  	pharynx  	 NNS	B-NP
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
2.13 	2.13 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.99 	1.99 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
larynx  	larynx  	 NNS	B-NP
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.57 	1.57 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.79 	1.79 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
oesophagus  	oesophagus  	 NNS	O
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.45 	1.45 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.41 	1.41 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
lung  	lung  	 NN	O
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.09 	1.09 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.13 	1.13 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
kidney  	kidney  	 NN	O
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.14 	1.14 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.15 	1.15 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
urinary  	urinary  	 JJ	B-NP
bladder  	bladder  	 NN	I-NP
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.29 	1.29 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.22 	1.22 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
thyroid  	thyroid  	 NNS	B-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.22  	1.22  	 CD	O
in  	in  	 IN	O
both  	both  	 DT	O
sexes 	sexes 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
Hodgkin  	Hodgkin  	 NNP	B-NP
lymphoma  	lymphoma  	 NNS	I-NP
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.59 	1.59 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.94 	1.94 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
non-Hodgkin  	non-Hodgkin  	 JJ	B-NP
lymphoma  	lymphoma  	 NNS	I-NP
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.13 	1.13 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.12 	1.12 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
for  	for  	 IN	O
the  	the  	 DT	O
heterogeneous  	heterogeneous  	 JJ	B-NP
group  	group  	 NN	I-NP
other  	other  	 JJ	O
sites  	sites  	 NNS	O
( 	( 	 -LRB-	O
SIR  	SIR  	 NNP	O
men 	men 	 NNS	O
:  	:  	 :	O
1.09 	1.09 	 CD	O
;  	;  	 :	O
SIR  	SIR  	 NNP	O
women 	women 	 NNS	O
:  	:  	 :	O
1.07 	1.07 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
men  	men  	 NNS	O
had  	had  	 VBD	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
MP  	MP  	 NNP	B-NP
risk  	risk  	 NN	I-NP
if  	if  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
cancer  	cancer  	 NN	O
was  	was  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
testis  	testis  	 NN	O
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.24 	1.24 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
while  	while  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
was  	was  	 VBD	O
true  	true  	 JJ	O
for  	for  	 IN	O
women  	women  	 NNS	O
with  	with  	 IN	O
gallbladder  	gallbladder  	 NNS	B-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.21 	1.21 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
skin  	skin  	 NN	B-NP
melanoma  	melanoma  	 NNS	I-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.17 	1.17 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
bone  	bone  	 NN	O
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.41 	1.41 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
breast  	breast  	 NN	O
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.12 	1.12 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
cervix  	cervix  	 FW	B-NP
uteri  	uteri  	 FW	I-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.23 	1.23 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
corpus  	corpus  	 JJ	B-NP
uteri  	uteri  	 NNS	I-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.23 	1.23 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
1.18 	1.18 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
On  	On  	 IN	O
the  	the  	 DT	O
contrary 	contrary 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
first  	first  	 JJ	O
liver  	liver  	 NN	O
or  	or  	 CC	O
pancreas  	pancreas  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
were  	were  	 VBD	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
decreased  	decreased  	 JJ	O
MP  	MP  	 NNP	B-NP
risk  	risk  	 NN	I-NP
in  	in  	 IN	O
both  	both  	 DT	O
sexes  	sexes  	 NNS	O
( 	( 	 -LRB-	O
liver  	liver  	 UH	O
SIR 	SIR 	 UH	O
:  	:  	 :	O
0.86  	0.86  	 CD	O
and  	and  	 CC	O
0.81  	0.81  	 CD	O
for  	for  	 IN	O
men  	men  	 NNS	O
and  	and  	 CC	O
women 	women 	 NNS	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
;  	;  	 :	O
pancreas  	pancreas  	 JJ	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
0.70  	0.70  	 CD	O
and  	and  	 CC	O
0.78  	0.78  	 CD	O
for  	for  	 IN	O
men  	men  	 NNS	O
and  	and  	 CC	O
women 	women 	 NNS	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
as  	as  	 RB	O
were  	were  	 VBD	O
those  	those  	 DT	O
of  	of  	 IN	O
colon  	colon  	 NN	O
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
0.93 	0.93 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
rectum  	rectum  	 NNS	O
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
0.83 	0.83 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
gallbladder  	gallbladder  	 NNS	B-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
0.80 	0.80 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
prostate  	prostate  	 NNS	B-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
0.93 	0.93 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
mesothelioma  	mesothelioma  	 NNS	B-NP
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
0.65 	0.65 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
central  	central  	 JJ	O
nervous  	nervous  	 JJ	O
system  	system  	 NN	O
( 	( 	 -LRB-	O
SIR 	SIR 	 NNP	O
:  	:  	 :	O
0.82 	0.82 	 CD	O
)  	)  	 -RRB-	O
among  	among  	 IN	O
men 	men 	 NNS	O
.  	.  	 .	O
Among  	Among  	 IN	O
the  	the  	 DT	O
cancers  	cancers  	 NNS	O
for  	for  	 IN	O
which  	which  	 WDT	O
the  	the  	 DT	O
EAR  	EAR  	 NNP	O
is  	is  	 VBZ	O
statistically  	statistically  	 RB	O
significant 	significant 	 JJ	O
,  	,  	 ,	O
those  	those  	 DT	O
with  	with  	 IN	O
higher  	higher  	 JJR	O
Excess  	Excess  	 NNP	O
Absolute  	Absolute  	 NNP	B-NP
Risk  	Risk  	 NN	I-NP
of  	of  	 IN	I-NP
MP  	MP  	 NNP	I-NP
were  	were  	 VBD	O
those  	those  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
oral  	oral  	 JJ	B-NP
cavity  	cavity  	 NNS	I-NP
( 	( 	 -LRB-	O
EAR 	EAR 	 NNP	O
:  	:  	 :	O
16.0  	16.0  	 CD	O
x  	x  	 SYM	O
1,000  	1,000  	 CD	O
person-years  	person-years  	 NN	B-NP
in  	in  	 IN	O
men  	men  	 NNS	O
and  	and  	 CC	O
5.4  	5.4  	 CD	O
in  	in  	 IN	O
women 	women 	 NNS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
pharynx  	pharynx  	 NNS	B-NP
( 	( 	 -LRB-	O
17.6  	17.6  	 CD	O
and  	and  	 CC	O
9.1 	9.1 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
larynx  	larynx  	 NNS	B-NP
( 	( 	 -LRB-	O
11.4  	11.4  	 CD	O
and  	and  	 CC	O
8.8 	8.8 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
oesophagus  	oesophagus  	 NNS	O
( 	( 	 -LRB-	O
8.5  	8.5  	 CD	O
and  	and  	 CC	O
4.8 	4.8 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
descriptive  	descriptive  	 JJ	B-NP
study  	study  	 NN	I-NP
provides  	provides  	 VBZ	O
quantitative  	quantitative  	 JJ	B-NP
information  	information  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
risk  	risk  	 NN	O
of  	of  	 IN	O
developing  	developing  	 VBG	O
a  	a  	 DT	O
second  	second  	 JJ	O
cancer  	cancer  	 NN	O
in  	in  	 IN	O
an  	an  	 DT	O
Italian  	Italian  	 JJ	O
population-based  	population-based  	 JJ	B-NP
cohort  	cohort  	 NN	I-NP
of  	of  	 IN	O
approximately  	approximately  	 RB	O
1.65  	1.65  	 CD	O
million  	million  	 CD	O
cancer  	cancer  	 NN	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
risk  	risk  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
general  	general  	 JJ	O
population 	population 	 NN	O
.  	.  	 .	O
During  	During  	 IN	O
the  	the  	 DT	O
follow-up  	follow-up  	 JJ	B-NP
time  	time  	 NN	I-NP
( 	( 	 -LRB-	O
on  	on  	 IN	O
average  	average  	 JJ	O
14  	14  	 CD	O
years 	years 	 NNS	O
)  	)  	 -RRB-	O
cancer  	cancer  	 NN	B-NP
patients  	patients  	 NNS	I-NP
had  	had  	 VBD	O
an  	an  	 DT	O
MP  	MP  	 NNP	B-NP
risk  	risk  	 NN	I-NP
that  	that  	 WDT	O
was  	was  	 VBD	O
10 	10 	 CD	O
%  	%  	 NN	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
comparison  	comparison  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
general  	general  	 JJ	O
population  	population  	 NN	O
and  	and  	 CC	O
an  	an  	 DT	O
Excess  	Excess  	 NNP	O
Absolute  	Absolute  	 NNP	B-NP
Risk  	Risk  	 NN	I-NP
of  	of  	 IN	O
1.32  	1.32  	 CD	O
x  	x  	 SYM	O
1,000  	1,000  	 CD	O
person-years 	person-years 	 NN	B-NP
.  	.  	 .	O
Study  	Study  	 NN	O
of  	of  	 IN	O
MPs  	MPs  	 JJ	O
and  	and  	 CC	O
their  	their  	 PRP$	O
risk  	risk  	 NN	B-NP
measures  	measures  	 NNS	I-NP
are  	are  	 VBP	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
methods  	methods  	 NNS	O
used  	used  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
calculation 	calculation 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
definition  	definition  	 NN	O
of  	of  	 IN	O
MP  	MP  	 NNP	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
univocal  	univocal  	 JJ	O
and  	and  	 CC	O
using  	using  	 VBG	O
different  	different  	 JJ	O
rules  	rules  	 NNS	O
can  	can  	 MD	O
greatly  	greatly  	 RB	O
change  	change  	 VB	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
cancers  	cancers  	 NNS	O
in  	in  	 IN	O
a  	a  	 DT	O
patient  	patient  	 NN	O
with  	with  	 IN	O
MPs 	MPs 	 JJ	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
AIRTUM  	AIRTUM  	 NNP	B-NP
cancer  	cancer  	 NN	I-NP
registries  	registries  	 RB	I-NP
adopt  	adopt  	 VB	O
the  	the  	 DT	O
same  	same  	 JJ	O
recommendations  	recommendations  	 NNS	B-NP
for  	for  	 IN	I-NP
MP  	MP  	 NNP	I-NP
definition 	definition 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
monograph  	monograph  	 NN	O
was  	was  	 VBD	O
therefore  	therefore  	 RB	O
made  	made  	 VBN	O
possible  	possible  	 JJ	O
by  	by  	 IN	O
the  	the  	 DT	O
shared  	shared  	 JJ	O
rules  	rules  	 NNS	O
and  	and  	 CC	O
standards  	standards  	 NNS	O
used  	used  	 VBN	O
by  	by  	 IN	O
AIRTUM  	AIRTUM  	 NNP	B-NP
registries 	registries 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
cancer  	cancer  	 NN	B-NP
site-specific  	site-specific  	 JJ	I-NP
sheets 	sheets 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
represent  	represent  	 VBP	O
the  	the  	 DT	O
core  	core  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
monograph 	monograph 	 NN	O
,  	,  	 ,	O
can  	can  	 MD	O
be  	be  	 VB	O
useful  	useful  	 JJ	O
to  	to  	 TO	O
highlight  	highlight  	 VB	O
and  	and  	 CC	O
quantify  	quantify  	 VB	O
the  	the  	 DT	O
bidirectional  	bidirectional  	 JJ	B-NP
associations  	associations  	 NNS	I-NP
among  	among  	 IN	O
different  	different  	 JJ	O
diseases  	diseases  	 NNS	O
and  	and  	 CC	O
therefore  	therefore  	 RB	O
provide  	provide  	 VB	O
indications  	indications  	 NNS	O
for  	for  	 IN	O
clinical  	clinical  	 JJ	B-NP
follow-up 	follow-up 	 NN	I-NP
.  	.  	 .	O
Lifestyle  	Lifestyle  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
in  	in  	 IN	O
more  	more  	 RBR	O
healthful  	healthful  	 JJ	O
directions  	directions  	 NNS	O
can  	can  	 MD	O
have  	have  	 VB	O
a  	a  	 DT	O
positive  	positive  	 JJ	B-NP
effect  	effect  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
cancer  	cancer  	 NN	B-NP
patient  	patient  	 NN	I-NP
population  	population  	 NN	I-NP
and  	and  	 CC	O
should  	should  	 MD	O
always  	always  	 RB	O
be  	be  	 VB	O
recommended 	recommended 	 VBN	O
.  	.  	 .	O
